Identification of colon tumor marker NKD1 via integrated bioinformatics analysis and experimental validation

被引:17
|
作者
Wang, Yue [1 ,2 ,3 ,4 ]
Yang, Chunxia [3 ,4 ]
Li, Wenjing [3 ,4 ]
Shen, Ying [3 ,4 ]
Deng, Jianzhong [3 ,4 ]
Lu, Wenbin [3 ,4 ]
Jin, Jianhua [3 ,4 ]
Liu, Yongping [1 ,2 ]
Liu, Qian [3 ,4 ]
机构
[1] Soochow Univ, Affiliated Hosp 3, Changzhou 213003, Jiangsu, Peoples R China
[2] Soochow Univ, Clin Oncol Lab, Changzhou Tumor Hosp, Changzhou, Peoples R China
[3] Jiangsu Univ, Dept Oncol, Wujin Hosp, Zhenjiang 213017, Jiangsu, Peoples R China
[4] Xuzhou Med Univ, Dept Oncol, Wujin Clin Coll, Xuzhou, Jiangsu, Peoples R China
来源
CANCER MEDICINE | 2021年 / 10卷 / 20期
基金
中国国家自然科学基金;
关键词
bioinformatics; colon cancer; NKD1; proliferation; WGCNA; DOWN-REGULATION; PROLIFERATION; EXPRESSION; PROMOTES;
D O I
10.1002/cam4.4224
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Colorectal cancer is an important death-related disease in the worldwide. However, specific colon cancer tumor markers currently used for diagnosis and treatment are few. The purpose of this study is to screen the potential colon cancer markers by bioinformatics and verify the results with experiments. Methods Gene expression data were downloaded from two different databases: TCGA database and GEO datasets, which were then analyzed by two different methods (difference analysis and WGCNA method). Venn and PPI analysis obtained the potential core genes, which were then performed the GO enrichment and KEGG pathway analysis. Expressions levels of NKD1 in colon carcinoma tissues were further confirmed by immunohistochemical staining and western blot assays. Moreover, the function was measured by MTT, clone formation, and tumor transplantation experiments. Importantly, co-immunoprecipitation, immunofluorescence, and protein stability assays were further performed to explore the underlying mechanism of NKD1 promoting cell proliferation. Results Nine potential core genes highly expressed in colon cancer samples were screened out by bioinformatics analysis. NKD1, one of the hub genes, highly expressed in the colon carcinoma tissues could enhance the proliferation of colon cancer cells. Mechanism research demonstrated that NKD1 was essential for the combination between Wnt signalosome (DVL) and beta-catenin, and that NKD1 knockout remarkably decreased the beta-catenin expression. Immunofluorescence assays further implied that NKD1 knockout significantly inhibited beta-catenin nuclear accumulation. Importantly, the stability of beta-catenin proteins was maintained by NKD1 in the colon cancer cells. Conclusion We believe that NKD1 well expressed in the colorectal carcinoma tissues can enhance the proliferation of colon cancer cells. Furthermore, the functions that NKD1 may have in colon cancer cells should be different from that NKD1 has played in the zebrafish. Thus, NKD1 could be a specific colorectal cancer marker.
引用
收藏
页码:7383 / 7394
页数:12
相关论文
共 50 条
  • [41] Identification of hub genes and biological pathways in glioma via integrated bioinformatics analysis
    Chen, Lulu
    Sun, Tao
    Li, Jian
    Zhao, Yongxuan
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2022, 50 (06)
  • [42] Identification of a 12-Gene Signature and Hub Genes Involved in Kidney Wilms Tumor via Integrated Bioinformatics Analysis
    Huang, Guoping
    Mao, Jianhua
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [43] Identification and Validation of Potential Pathogenic Genes and Prognostic Markers in ESCC by Integrated Bioinformatics Analysis
    Tang, Lu
    Chen, Yuqiao
    Peng, Xiong
    Zhou, Yuan
    Jiang, Hong
    Wang, Guo
    Zhuang, Wei
    FRONTIERS IN GENETICS, 2020, 11
  • [44] Identification of key immune genes related to lymphatic metastasis of papillary thyroid cancer via bioinformatics analysis and experimental validation
    Yu, Yang
    Guo, Xing
    Chai, Jian
    Han, Zhuoyi
    Ji, Yaming
    Sun, Jirui
    Zhang, Huiqing
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [45] Identification and validation of the high expression of pseudogene TCAM1P in cervical cancer via integrated bioinformatics analysis (vol 22, 17, 2022)
    Zhu, Yuanhang
    Ren, Chenchen
    Yang, Li
    Zhang, Zhenan
    Gong, Meiyuan
    Chen, Kebing
    CANCER CELL INTERNATIONAL, 2022, 22 (01)
  • [46] Identification of Hub Genes Correlated With Poor Prognosis for Patients With Uterine Corpus Endometrial Carcinoma by Integrated Bioinformatics Analysis and Experimental Validation
    Yuan, Yi
    Chen, Zhengzheng
    Cai, Xushan
    He, Shengxiang
    Li, Dong
    Zhao, Weidong
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [47] Identification and validation of key genes with prognostic value in non-small-cell lung cancer via integrated bioinformatics analysis
    Wang, Li
    Qu, Jialin
    Liang, Yu
    Zhao, Deze
    Rehman, Faisal U. L.
    Qin, Kang
    Zhang, Xiaochun
    THORACIC CANCER, 2020, 11 (04) : 851 - 866
  • [48] Identification and validation of diagnostic biomarkers of coronary artery disease progression in type 1 diabetes via integrated computational and bioinformatics strategies
    Zhou, Yufei
    Liu, Chunjiang
    Zhang, Zhongzheng
    Chen, Jian
    Zhao, Di
    Li, Linnan
    Tong, Mingyue
    Zhang, Gang
    COMPUTERS IN BIOLOGY AND MEDICINE, 2023, 159
  • [49] Identification of miR-1 and miR-499 in chronic atrial fibrillation by bioinformatics analysis and experimental validation
    Chen, Xinpei
    Zhang, Yu
    Meng, He
    Chen, Guiying
    Ma, Yongjiang
    Li, Jian
    Liu, Saizhe
    Liang, Zhuo
    Xie, Yinuo
    Liu, Ying
    Guo, Hongyang
    Wang, Yutang
    Shan, Zhaoliang
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2024, 11
  • [50] Identification of key genes and microRNAs involved in kidney Wilms tumor by integrated bioinformatics analysis
    Zhang, Lei
    Gao, Xian
    Zhou, Xiang
    Qin, Zhiqiang
    Wang, Yi
    Li, Ran
    Tang, Min
    Wang, Wei
    Zhang, Wei
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2019, 18 (04) : 2554 - 2564